Rosen Law Firm Invites Park Ha Biological Technology Investors to Securities Lawsuit

Rosen Law Firm, a global investor rights law firm, is notifying purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) that they may have the opportunity to participate in a securities lawsuit. The class period for this action is specified as between December 27, 2024, and July 8, 2025, inclusive.

The firm urges investors who acquired Park Ha Biological Technology securities during this timeframe to contact them promptly to learn more about their rights and the litigation. A specific deadline for filing claims has been set for September. While the exact grounds for the lawsuit were not detailed in the release, such actions typically allege that a company made misleading statements or omissions regarding its financial condition, business prospects, or other material information.

Park Ha Biological Technology Co., Ltd. is a biotechnology company listed on the NASDAQ exchange. The firm's announcement suggests potential concerns regarding the company's disclosures during the specified period. Investors are advised to consult with legal counsel to understand the implications of such litigation.

Rosen Law Firm has a history of representing investors in securities fraud class actions. This development could impact the company's stock performance and reputation, depending on the progression and outcome of the legal proceedings.